.Novo Nordisk is proceeding its own press in to hereditary medications, accepting to compensate Nano...
.Innovent Biologics has created the case that its checkpoint inhibitor-cytokine fusion protein has a...
.A phase 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (...
.Five months after Rakovina Therapeutics pivoted toward expert system, the cancer-focused biotech ha...
.Ascendis Pharma has become a prospective threat to BioMarin's Voxzogo, disclosing phase 3 growth di...
.Though Alkeus Pharmaceuticals' oral eye condition asset failed to considerably decrease geographica...
.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually simple to miss a small...
.Immune system gate inhibitors are actually the superheroes of cancer therapy. Medicines like Bristo...
.Accept to today's Chutes & Ladders, our summary of significant leadership hirings, firings as we...
.Regeneron is actually back along with long-term follow-up for its LAG-3 prevention and also PD-1 in...